7
podcast episode
Ep. 108: No Silos, with Google Health’s David Feinberg and FasterCures’ Esther Krofah
“What we've really tried to do is get information out there to the public, to researchers, to publ
ic health folks, so they can make better decisions about what's happening so that we can all get through this.” - David Feinberg of Google Health
+ Read More
article
FasterCures Quarterly Update: July 2023
In This Issue:
Convenings Recap
Policy Updates
FasterCures in the Media
FasterCures in the Communit
y
+ Read More
report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
+ Read More
article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically
Dr. Robert Califf
Commissioner
US Food and Drug Administration
Silver Spri
ng, MD 20993
Dear Dr. Califf,
+ Read More
article
Comment Letter: Food and Drug Administration (FDA) – Medical Device User Fee Act (MDUFA)
Dear Commissioner Hahn:
article
Data Collection for Cell and Gene Therapies: Perspectives from the Front Lines
table td{padding:10px;}
In this Summary
Introduction
Framing the Challenge
Recommendations
Conclus
ion
+ Read More
article
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Submitted electronically